View in EDS HTML Full Text PDF Full Text

Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.
Authors: Mort, Joseph F.1 (AUTHOR), Brighton, David2 (AUTHOR), DiBenedetto, Samantha1 (AUTHOR), Wells, Leah1 (AUTHOR), Clark, Stephen M.3 (AUTHOR), Reid, Justin3 (AUTHOR), Patel, Imari4 (AUTHOR), Jackson, Clayton5 (AUTHOR), Yelvington, Bradley6 (AUTHOR), Miller, Ryan6 (AUTHOR), Perciavalle, Matthew6 (AUTHOR), Walsh, Katherine7 (AUTHOR), Wolfe, Heather8 (AUTHOR), Locke, Susan C.9 (AUTHOR), Zeidner, Joshua F.3 (AUTHOR), Duong, Vu H.4 (AUTHOR), Reed, Daniel R.5 (AUTHOR), Dholaria, Bhagirathbhai7 (AUTHOR), LeBlanc, Thomas W.8 (AUTHOR), Keng, Michael1 (AUTHOR)
Source: European Journal of Haematology. Mar2025, Vol. 114 Issue 3, p481-494. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.14354